Items where Author is "Okada, Hideho"
Group by: Item Type | No Grouping Jump to: Article Number of items: 7. ArticleKohanbash, Gary and Okada, Kaori and Liu, Shuming and Lin, Yi and Shrivastav, Shruti and Nicolaides, Theodore and Mueller, Sabine and Pollack, Ian and Carcaboso, Angel and Hou, Yafei and Okada, Hideho (2016) NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION. NEURO-ONCOLOGY, 18. 67 - 67. ISSN 1522-8517 Kohanbash, Gary and Shrivastav, Shruti and Ahn, Brian and Hou, Yafei and Costello, Joseph and Okada, Hideho (2015) IDH mutation-induced suppression of type-1 anti-glioma immune response. Journal for ImmunoTherapy of Cancer, 3 (S2). Kohanbash, Gary and Straw, Erin and Ahn, Brian and Okada, Hideho (2014) ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth. Journal for ImmunoTherapy of Cancer, 2 (S3). Ohkuri, Takayuki and Ghosh, Arundhati and Kosaka, Akemi and Zhu, Jianzhong and Ikeura, Maki and David, Michael and Watkins, Simon C and Sarkar, Saumendra N and Okada, Hideho (2014) STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment. Journal for ImmunoTherapy of Cancer, 2 (Suppl ). P228 - P228. ISSN 2051-1426 Okada, Hideho and Butterfield, Lisa H and Hamilton, Ronald L and Salazar, Andres M and Potter, Douglas M and Lieberman, Frank S and Pollack, Ian F (2013) Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas. Journal for ImmunoTherapy of Cancer, 1 (S1). Ohno, Masasuke and Ohkuri, Takayuki and Kosaka, Akemi and Tanahashi, Kuniaki and June, Carl H and Natsume, Atsushi and Okada, Hideho (2013) Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts. Journal for ImmunoTherapy of Cancer, 1 (1). 21 - 21. ISSN 2051-1426 Forero, Ivan Martinez and Okada, Hideho and Topalian, Suzanne L and Gajewski, Thomas F and Korman, Alan J and Melero, Ignacio (2012) Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011. Journal of Translational Medicine, 10 (1). |